Andra AP fonden Increases Position in Corteva, Inc. $CTVA

Andra AP fonden lifted its stake in Corteva, Inc. (NYSE:CTVA) by 369.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 222,700 shares of the company’s stock after purchasing an additional 175,300 shares during the period. Andra AP fonden’s holdings in Corteva were worth $15,061,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Norges Bank acquired a new stake in shares of Corteva during the 2nd quarter valued at approximately $434,220,000. Pacer Advisors Inc. increased its stake in Corteva by 4,007.1% in the 3rd quarter. Pacer Advisors Inc. now owns 2,442,177 shares of the company’s stock valued at $165,164,000 after purchasing an additional 2,382,715 shares in the last quarter. Marshall Wace LLP raised its holdings in Corteva by 1,365.9% during the second quarter. Marshall Wace LLP now owns 1,809,764 shares of the company’s stock worth $134,882,000 after purchasing an additional 1,686,309 shares during the last quarter. National Pension Service boosted its position in Corteva by 148.4% during the second quarter. National Pension Service now owns 2,454,601 shares of the company’s stock worth $182,941,000 after purchasing an additional 1,466,268 shares in the last quarter. Finally, Qube Research & Technologies Ltd grew its holdings in Corteva by 566.0% in the second quarter. Qube Research & Technologies Ltd now owns 1,247,120 shares of the company’s stock valued at $92,948,000 after purchasing an additional 1,059,872 shares during the last quarter. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Corteva Stock Up 1.5%

Shares of NYSE CTVA opened at $80.01 on Friday. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07. The stock has a market capitalization of $53.81 billion, a PE ratio of 50.64, a P/E/G ratio of 2.69 and a beta of 0.75. The firm has a fifty day moving average of $71.91 and a 200-day moving average of $68.83. Corteva, Inc. has a 52-week low of $53.40 and a 52-week high of $80.23.

Corteva (NYSE:CTVA) last issued its earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.22. The firm had revenue of $3.91 billion for the quarter, compared to analysts’ expectations of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The firm’s revenue for the quarter was down 1.7% compared to the same quarter last year. During the same quarter last year, the firm earned $0.32 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, analysts anticipate that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be issued a $0.18 dividend. The ex-dividend date is Monday, March 2nd. This represents a $0.72 annualized dividend and a yield of 0.9%. Corteva’s dividend payout ratio (DPR) is presently 45.57%.

Insider Transactions at Corteva

In other news, insider Brian Titus sold 8,311 shares of the stock in a transaction on Friday, February 20th. The shares were sold at an average price of $76.55, for a total value of $636,207.05. Following the completion of the sale, the insider owned 8,090 shares of the company’s stock, valued at $619,289.50. This represents a 50.67% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.14% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several equities research analysts recently commented on CTVA shares. Weiss Ratings reiterated a “hold (c-)” rating on shares of Corteva in a research report on Monday, December 29th. Royal Bank Of Canada upped their price target on shares of Corteva from $80.00 to $89.00 and gave the company an “outperform” rating in a report on Thursday, February 5th. UBS Group cut shares of Corteva from a “buy” rating to a “hold” rating in a research note on Monday, February 9th. The Goldman Sachs Group reiterated a “buy” rating and set a $88.00 target price on shares of Corteva in a report on Thursday, February 5th. Finally, Citigroup raised their price target on Corteva from $74.00 to $80.00 and gave the stock a “neutral” rating in a research report on Thursday, February 5th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have issued a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $82.30.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.